Dossier
drug design
Coverage of drug design in the Nexus archive.
- Jeff Bezos’s Prometheus raises $12B to build an ‘artificial general engineer’ for the physical world
Jeff Bezos's Prometheus has raised $12 billion in a new funding round, valuing the physical AI startup at $41 billion. The company aims to develop an 'artificial general engineer' to automate heavy engineering and drug design processes.
- Sir Demis Hassabis wants to automate drug design
Sir Demis Hassabis, CEO of Google DeepMind, aims to automate drug design. The article highlights his leadership in advancing AI applications for healthcare innovation.